90
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
May 31, 2012
PF-04531083
2000 mg oral solution
Placebo
Placebo tablets for Ibuprofen
PF-04531083
1000 mg oral solution
Placebo
Placebo tablets for Ibuprofen
Ibuprofen
2 x 200 mg tablets
Placebo
Placebo solution for PF-04531083
Placebo
Placebo solution for PF-04531083
Placebo
Placebo tablets for Ibuprofen
Pfizer Investigational Site, Austin
Lead Sponsor
Pfizer
INDUSTRY